Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute’s Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.

Guest:

Hannah Mamuszka is Founder & CEO of ALVA10, a healthcare technology firm. Hannah has spent her 20+ year career in diagnostics – both in pharma and at diagnostics companies, in the lab and on the business side. She believes that the challenges of diagnostic technology fully impacting patient care are more commercial than technical, and conceived of ALVA10 to create a mechanism to pull technology into healthcare by aligning incentives through data. She regularly speaks on issues regarding advancement of technology in healthcare, is on the Board of Directors for two diagnostic companies and writes a column on the value of diagnostics for the Journal of Precision Medicine.

Guest Host:

Dr. William S. Smith is Pioneer’s Visiting Fellow in the Life Sciences. Dr. Smith has 25 years of experience in government and in corporate roles. His career includes senior staff positions for the Republican House leadership on Capitol Hill, the White House Office of National Drug Control Policy, and the Massachusetts Governor’s office where he served under Governors Weld and Cellucci. He spent ten years at Pfizer Inc as Vice President of Public Affairs and Policy where he was responsible for Pfizer’s corporate strategies for the U.S. policy environment. He later served as a consultant to major pharmaceutical, biotechnology and medical device companies. Dr. Smith earned his PhD in political science with distinction at The Catholic University of America.

Get new episodes of Hubwonk in your inbox!

Recent episodes:

Economic Long Covid: Mixed Health Messages for Baystate Businesses

Hubwonk host Joe Selvaggi talks with NFIB’s Chris Carlozzi and Retailers Association of Massachusetts' Jon Hurst about the challenges and future prospects for businesses as they adapt to widespread consumer confusion caused by vague and often conflicting public health messaging from our political leadership.

Enduring the Maelstrom: Lessons from MassPort Leadership During 9/11

Hubwonk host Joe Selvaggi talks with author and former MassPort CEO Virginia Buckingham about her recently released book, On My Watch: A Memoir, which chronicles her experience leading the organization through 9/11 and the life and leadership lessons learned from that tragic day.

Rescuing Afghan Refugees: Finding Redemption amidst the Wreckage of Collapse

Hubwonk host Joe Selvaggi talks with Jeffrey Thielman, President and CEO of the International Institute of New England, about the path refugees must take to resettle in the US, how organizations like his facilitate and integrate refugees including those recently displaced in Afghanistan, and what individuals concerned about the fate of refugees can do to support their resettlement. 

Untangling Variants & Outbreaks: Can Vaccines & Natural Immunity Outrun Delta?

Hubwonk host Joe Selvaggi talks with author, surgeon, and public health expert Dr. Marty Makary about the COVID-19 Delta Variant, the durability of natural and vaccinated immunity, the benefits of booster shots, and the health risks for children as we move into the fall.

Targeting Pharma: Infrastructure Bill Employs Price Controls To Offset Unprecedented Price Tag

Hubwonk host Joe Selvaggi talks with Pioneer Institute Visiting Fellow in Life Sciences Dr. William Smith about how the price control features of the emerging $3.5 trillion infrastructure bill might affect the pharmaceutical Industry, both nationwide and here in Massachusetts, and what effect that change will have on drug consumers.

Examining Eviction Moratoriums: Testing Constitutional Limits of Executive Branch Power

Hubwonk host Joe Selvaggi talks with constitutional scholar and George Mason Law Professor Ilya Somin about the flaws and legal vulnerabilities of the first and second CDC eviction moratoriums and discuss what current and future court rulings will mean for the limits of executive agency powers.

Pandemic Pension Payout: Essential COVID-19 Public Workers Rewarded Whether Essential or Working

Hubwonk host Joe Selvaggi talks with Pioneer Institute’s Director of Research and former Massachusetts Inspector General and State Representative Greg Sullivan about HB 2808, COVID-19 Essential Employee Retirement Credit Bonus, discussing the merits of the recently proposed joint bill, its cost, and our current public debt burden in the Commonwealth.

College Debt Explained: Education Pays When Students Choose Wisely

Hubwonk host Joe Selvaggi talks with American Enterprise Institute resident fellow and education economist Beth Akers about the American student debt crisis (totalling $1.6 trillion). They explore who borrows, who is in debt, and which policy choices might best serve the financial needs of every student. 

Chasing Election Integrity: Strict Voter ID Laws’ Impact on Turnout and Fraud

Joe Selvaggi talks with Harvard Business School Professor Vincent Pons about his recently released NBER paper on the effects of strict voter ID laws on voter behavior and fraud across the United States over 10 years, examining the results of the 1.6 billion observation dataset by age, race, gender, and party affiliation.

The Oldest Hatred: Calling Out Antisemitism In Its Many Forms

Hubwonk host Joe Selvaggi talks with Boston Globe opinion writer Jeff Jacoby about the troubling increase in antisemitic incidents, including the recent attack on a Boston rabbi, and how our current political rancor fans the flames of bigotry nationwide.